Eastman Chemical Q2 2024 Adj EPS $2.15 Beats $2.01 Estimate, Sales $2.36B Inline
Portfolio Pulse from Benzinga Newsdesk
Eastman Chemical (NYSE:EMN) reported Q2 2024 adjusted EPS of $2.15, beating the analyst estimate of $2.01. Quarterly sales were $2.36 billion, in line with expectations and up 1.68% year-over-year.
July 25, 2024 | 8:19 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Eastman Chemical's Q2 2024 adjusted EPS of $2.15 beat estimates by 6.97%, while sales of $2.36 billion met expectations and increased 1.68% year-over-year.
The better-than-expected EPS and in-line sales performance indicate strong operational efficiency and stable revenue growth, likely boosting investor confidence and positively impacting the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100